cathepsin D Antibodies

Santa Cruz Biotechnology provides a broad selection of cathepsin D monoclonal antibodies for research applications. Cathepsin D monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cathepsin D is a lysosomal aspartic protease that plays a vital role in protein degradation and processing within cells. The protein is involved in various physiological processes, including antigen presentation, apoptosis, and tissue remodeling. Dysregulation of cathepsin D has been implicated in several diseases, including cancer and neurodegenerative disorders, making it an important target for research. Cathepsin D research has revealed significant insights into cellular protein degradation mechanisms and their impact on disease progression. Understanding cathepsin D function continues to be crucial for developing therapeutic strategies for various pathological conditions. Ongoing studies of cathepsin D contribute to expanding knowledge about lysosomal proteases and their roles in cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cathepsin D's role in health and disease.